Human leukocyte antigen expression in sepsis: What have we learned?

Critical Care Medicine

Volumn 33, Issue 1, 2005, Pages 236-237

  Tschoeke, Sven K ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Gene expression; Immunomodulation; Inflammation; Septic shock

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DM ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POLYMYXIN B; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; CELL COUNT; EDITORIAL; HEMOFILTRATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; PLASMAPHERESIS; PRIORITY JOURNAL; RNA EXTRACTION; SEPSIS; SEPTIC SHOCK; TRANSCRIPTION REGULATION; TREATMENT OUTCOME;

CRITICAL CARE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; MONOCYTES; RNA, MESSENGER; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRIPTION, GENETIC;

EID: 12244309507     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000150835.66819.CA     Document Type: Editorial

References (24)

1. Pachot A, Monneret G, Brion A, et al: Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 2005; 33:31-38
2. Volk HD, et al: Monocyte deactivation - Rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996; 22(suppl 4):S474-481
3. Ting JP, Trowsdale J: Genetic control of MHC class II expression. Cell 2002; 109(suppl): S21-33
4. Koppelman B, et al: Interleukin-10 downregulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997; 7:861-871
5. Krakauer T, Oppenheim JJ: IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 1993; 150:1205-1211
6. Schwiebert LM, et al: Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol 1995; 165:12-19
7. Watanabe Y, Lee S, Allison AC: Control of the expression of a class II major histocompatibility gene (HLA-DR) in various human cell types: down-regulation by IL-1 but not by IL-6, prostaglandin E2, or glucocorticoids. Scand J Immunol 1990; 32:601-609
8. Basta PV, et al: A beta-adrenergic agonist modulates DR alpha gene transcription via enhanced cAMP levels in a glioblastoma multiforme line. J Immunol 1989; 142: 2895-2901
9. Perry SE, et al: Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis? Intensive Care Med 2003; 29: 1245-1252
10. Oczenski W, et al: HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 2003; 29:1253-1257
11. Hershman MJ, et al: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77:204-207
12. Lekkou A, et al: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11:161-167
13. Randow F, et al: Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995; 181:1887-1892
14. Monneret G, et al: The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004; 95:193-198
15. Gogos CA, et al: Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 2000; 181: 176-180
16. Le Tulzo Y, et al: Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 2004; 169:1144-1151
17. Bontron S, et al: Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol Cell Biol 1997; 17: 4249-4258
18. Steimle V, et al: Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994; 265:106-109
19. Docke WD, et al: Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 1997; 3:678-681
20. Nierhaus A, et al: Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 2003; 29:646-651
21. Flohe S, et al: Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 2003; 31:2462-2469
22. Ono S, et al: Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 2004; 188: 150-156
23. Nakos G, et al: Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 2002; 30: 1488-1494
24. Hornell TM, et al: Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. J Immunol 2003; 171: 2374-2383